rcs research tirzepatide Compound Retatrutide RCS Research Peptides |

University of Oklahoma researcher Elizabeth Wellberg, Ph.D., is the senior author of a review article in The Journal of Clinical Investigation that gathers current research evidence about the effects of GLP-1 drugs, like Ozempic and Zepbound, on cancer risk.

Training won't fix glandular tissue

Menos decisiones

Type 2 diabetes (T2D) and obesity are prevalent metabolic disorders affecting millions of individuals worldwide

With the steady increase in obesity rates, GLP-1 drugs seem like a convenient solution

Doug Long, VP, industry relations, IQVIA, discusses how soaring demand for GLP-1 therapies is driving reimbursement challenges, shifting distribution models, and expanding the drugs potential into new therapeutic areas.